
Pixee Medical is a medical technology company that develops augmented reality (AR) solutions for orthopedic surgery. Their flagship product, Knee+ NexSight, is an AR-assisted total knee arthroplasty solution that integrates seamlessly into existing workflows, requiring minimal training and no bulky equipment or disposables. The system provides surgeons with an intuitive AR interface and high-precision tools for accurate and efficient guidance during surgery, aiming to improve surgeon results and patient outcomes. Pixee Medical's technology offers full control to surgeons in a cost-effective way, by eliminating consumables and designing reusable components. The company was founded in France in 2017 and has expanded its presence to the United States, with its solutions used in over 10,000 procedures in more than 20 countries.

Pixee Medical is a medical technology company that develops augmented reality (AR) solutions for orthopedic surgery. Their flagship product, Knee+ NexSight, is an AR-assisted total knee arthroplasty solution that integrates seamlessly into existing workflows, requiring minimal training and no bulky equipment or disposables. The system provides surgeons with an intuitive AR interface and high-precision tools for accurate and efficient guidance during surgery, aiming to improve surgeon results and patient outcomes. Pixee Medical's technology offers full control to surgeons in a cost-effective way, by eliminating consumables and designing reusable components. The company was founded in France in 2017 and has expanded its presence to the United States, with its solutions used in over 10,000 procedures in more than 20 countries.
Headquarters: Besançon, France (U.S. office in Cambridge, MA)
Founded: 2017
Product: Knee+ / Knee+ NexSight AR navigation for total knee arthroplasty
Clinical Use: Used in over 10,000 procedures in 20+ countries
Recent Funding: Series B (Feb 2024), lead investor Relyens
Orthopedic surgical navigation for total knee arthroplasty
2017
Medical technology (medtech)
15090000.00 USD
Round reported in Feb 2024 with additional participants including UI Investissement, Bpifrance, Angelor, Innovacom.
“Backed by institutional investors including Relyens, UI Investissement, Bpifrance, Angelor, Innovacom”